Carbenicillin therapy of Pseudomonas and other gram-negative bacillary infections.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002512:Cephalothin / Q000627:therapeutic use; D002648:Child; D004342:Drug Hypersensitivity; D004802:Eosinophilia / Q000139:chemically induced; D005260:Female; D005334:Fever / Q000139:chemically induced; D006801:Humans; D066298:In Vitro Techniques; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D007612:Kanamycin / Q000627:therapeutic use; D008171:Lung Diseases / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D010403:Penicillin Resistance; D010406:Penicillins / Q000008:administration & dosage*; D010532:Peritoneal Diseases / Q000188:drug therapy; D011511:Proteus / Q000472:pathogenicity; D011512:Proteus Infections / Q000188:drug therapy; D011552:Pseudomonas Infections / Q000188:drug therapy*; D011550:Pseudomonas aeruginosa / Q000472:pathogenicity; D014552:Urinary Tract Infections / Q000188:drug therapy
D010406:Penicillins; D007612:Kanamycin; D002512:Cephalothin